HEALTH
Jay Hancock | January 17, 2012
Four years ago, doctors at Chesapeake Urology Associates started ordering the most expensive kind of prostate-cancer therapy for many more of their patients. Before 2007, the large, multi-office practice was prescribing the treatment, known as intensity modulated radiation therapy, for 12 percent of its prostate-cancer patients covered by Medicare, according to data compiled by a Georgetown University researcher. But starting in mid-2007, Chesapeake Urology's referral rate for IMRT more than tripled, rising to 43 percent of the Medicare cases.
HEALTH
By Meredith Cohn | January 11, 2012
Researchers at Johns Hopkins and the University of Michigan have discovered an inherited mutation linked to significantly higher risk of prostate cancer development at a younger age. The discovery, after two decades of looking, provides insight into the disease development. And though those with the mutation comprise just a fraction of the 240,000 new cases diagnosed annually, the discovery could also help doctors determine who needs earlier screening. The discovery is the first major genetic variant found for inherited prostate cancer, said Dr. Kathleen A. Cooney, professor of internal medicine and urology at the Michigan Medical School and a senior author of the study, which was published in the New England Journal of Medicine . The study found that those with a family history of prostate cancer were much more likely to have the mutation, and that gave them a 10-20 higher risk of developing the disease themselves.
NEWS
By Frederick N. Rasmussen, The Baltimore Sun | December 4, 2011
Anthony O'Neill "Tony" Miller, a retired reporter and foreign correspondent, died Nov. 23 of prostate cancer at his home in Cuernavaca, Mexico. The former Ellicott City resident was 68. Born in Baltimore and raised in Catonsville, Mr. Miller was a 1961 graduate of Loyola High School and earned a bachelor's degree in political science in 1965 from what is now Loyola University Maryland. After working as a social worker for the city Department of Social Services and studying psychology, Mr. Miller left Baltimore in the early 1970s and went to California, where he began reporting for the San Jose Mercury and later the Sacramento Bee. He became the primary researcher for authors George Klineman, Sherman Butler and David Conn, whose book, "The Cult That Died: The Tragedy of Jim Jones and the People's Temple," published in 1990, told the story of the 1978 Jonestown Massacre in Guyana.
NEWS
By Meredith Cohn, The Baltimore Sun | October 20, 2011
The devastation of losing a house to foreclosure can lead to depression and a host of other conditions, according to the authors of new study who warn of a looming national health crisis. They are advocating for a new unified approach by financial and mental health advisers to provide homeowners with aid. The study, led by a University of Maryland researcher, found that one in five people in default on their mortgages have serious symptoms of depression. About one-third have seen their finances so crimped that they cannot afford to fill prescriptions and get enough to eat, which worsen health problems.
HEALTH
By Meredith Cohn, The Baltimore Sun | October 19, 2011
The U.S. Preventive Services Task Force, an independent advisory panel, recently recommended that healthy men not be given PSA blood tests to detect prostate cancer. But that won't mean the end of diagnosis and treatment of the disease, the most common cancer and the second most common cause of cancer death in American men. Dr. E. James Wright, associate professor and director of the Division of Reconstructive and Neurological Urology and chief of urology at Johns Hopkins Bayview Medical Center, answers questions about diagnosis and the latest treatments, including measures to mitigate side effects such as incontinence and impotence.
NEWS
October 11, 2011
The U.S. Preventive Services Task Force's recommendation against routine use of a blood test that can offer early detection of prostate cancer has led to puzzlement and anger. The reaction has been similar to that following the group's suggestion two years ago that routine mammograms be sharply curtailed. As with mammograms and breast cancer , many of those who received treatment for prostate cancer after a blood test showed elevated levels of prostate-specific antigen - a marker for prostate cancer - are convinced that the screening saved their lives.